Category: Press Releases

Fifty Governments Stand Firm on the Drive for Economic Resilience

Rotterdam, the Netherlands, April 16, 2025 (GLOBE NEWSWIRE) — The Global Center on Adaptation (GCA) today hosted an inaugural Ambassadors’ Forum galvanizing global support for accelerating adaptation at speed and at scale. The event, hosted at the GCA’s Rotterdam Headquarters, called on governments, industries and civil society to redouble efforts to build “resilient economies” as the growth engine for the 21st century. Ambassadors and senior diplomatic representatives from 50 nations gathered in a show of support and unity for the adaptation and resilience agenda. Delegates committed to spurring sustainable growth, fostering new industries, driving innovation, and unlocking private finance to ease

Continue Reading

Fifty Governments Stand Firm on the Drive for Economic Resilience

Rotterdam, the Netherlands, April 16, 2025 (GLOBE NEWSWIRE) — The Global Center on Adaptation (GCA) today hosted an inaugural Ambassadors’ Forum galvanizing global support for accelerating adaptation at speed and at scale. The event, hosted at the GCA’s Rotterdam Headquarters, called on governments, industries and civil society to redouble efforts to build “resilient economies” as […]

Continue Reading

Sabin Begins Marburg Vaccine Trial in U.S.

Sabin Begins Marburg Vaccine Clinical Trial in U.S. WASHINGTON, April 16, 2025 (GLOBE NEWSWIRE) — The Sabin Vaccine Institute has launched a multi-site Phase 2 clinical trial in the U.S. for its Marburg vaccine candidate, administering doses to the first participants in Melbourne, Florida. This trial builds on ongoing Phase 2 testing in Kenya and […]

Continue Reading

Sabin Begins Marburg Vaccine Trial in U.S.

Sabin Begins Marburg Vaccine Clinical Trial in U.S. Sabin begins a multi-site Phase 2 clinical trial of its Marburg vaccine candidate in U.S. WASHINGTON, April 16, 2025 (GLOBE NEWSWIRE) — The Sabin Vaccine Institute has launched a multi-site Phase 2 clinical trial in the U.S. for its Marburg vaccine candidate, administering doses to the first participants in Melbourne, Florida. This trial builds on ongoing Phase 2 testing in Kenya and Uganda, with initial findings from that research expected in the coming months. Sabin’s vaccine development efforts, including clinical trials, are becoming increasingly critical as Marburg outbreaks grow in frequency, underscoring

Continue Reading